-+ 0.00%
-+ 0.00%
-+ 0.00%

Dermata Therapeutics Announces Presentation of Phase 3 Clinical Trial Results for XYNGARI™ at EADV Congress 2025

Reuters·09/17/2025 05:00:21

Please log in to view news